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West Nile virus (WNV) causes a severe zoonosis, which can lead to a large number
of casualties and considerable economic losses. A rapid and accurate identification
method for WNV for use in field laboratories is urgently needed. Here, a method
utilizing reverse transcription loop-mediated isothermal amplification combined with a
vertical flow visualization strip (RT-LAMP-VF) was developed to detect the envelope
(E) gene of WNV. The RT-LAMP-VF assay could detect 102 copies/µl of an WNV
RNA standard using a 40 min amplification reaction followed by a 2 min incubation
of the amplification product on the visualization strip, and no cross-reaction with other
closely related members of the Flavivirus genus was observed. The assay was further
evaluated using cells and mouse brain tissues infected with a recombinant rabies virus
expressing the E protein of WNV. The assay produced sensitivities of 101.5 TCID50/ml
and 101.33 TCID50/ml for detection of the recombinant virus in the cells and brain tissues,
respectively. Overall, the RT-LAMP-VF assay developed in this study is rapid, simple and
effective, and it is therefore suitable for clinical application in the field.
Keywords: West Nile virus, visual detection, reverse transcription loop-mediated isothermal amplification,
visualization strip, RT-LAMP-VF
INTRODUCTION
West Nile virus (WNV) infection leads to an acute febrile zoonosis, which can cause disease in
birds, humans and horses1 (Gubler, 2001). The manifestations of WNV infection include West
Nile fever and West Nile encephalitis, which together comprise symptoms ranging from a benign
or often symptomless infection to fever and neuroinvasive disease (Gubler, 2001; Sejvar et al., 2003;
Hayes and O’Leary, 2004; Hayes and Gubler, 2006). WNV infection gained worldwide attention in
1http://www.oie.int/en/for-the-media/animal-diseases/animal-disease-information-summaries/
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1999, when it was first detected in America during an outbreak
in New York City (Nash et al., 2001; Hayes and Gubler, 2006). In
America, as of January 12, 2016, a total of 48 states have reported
WNV infection in humans, birds, or mosquitoes2.
WNV is an arthropod-borne, neurotropic, enveloped
Flavivirus with a single-stranded, positive-sense RNA genome
and is a member of the Japanese encephalitis virus (JEV)
serogroup, which includes JEV, Murray Valley encephalitis virus
(MVEV) and St. Louis encephalitis virus (Mukhopadhyay et al.,
2003; Solomon et al., 2003; Lim et al., 2011). The RNA genome of
WNV is approximately 11,000 nucleotides in length and encodes
three structural [capsid (C), premembrane (prM) or membrane
(M), and envelope (E)] proteins and seven non-structural (NS1,
NS2a, NS2b, NS3, NS4a, NS4b, and NS5) proteins (Deubel et al.,
2001; Brinton, 2002; Parida et al., 2004). Phylogenetic analysis
of the WNV E protein sequence has indicated that WNV can
be separated into two main lineages (lineages 1 and 2) as well as
several additional minor lineages (lineage 3, lineage 4, lineage 5
and the putative lineage 6; Lanciotti et al., 2002; Vazquez et al.,
2010; Del Amo et al., 2013; Faggioni et al., 2014).
There are many laboratory methods for diagnosing
WNV, including virus isolation, immunohistochemistry,
immunofluorescence, plaque reduction neutralization test
(PRNT), enzyme-linked immunosorbent assay (ELISA), reverse
transcription PCR (RT-PCR), real-time RT-PCR, and nested
RT-PCR, among others (Dauphin and Zientara, 2007; De Filette
et al., 2012). Some of these methods have been approved by
the American Centers for Disease Control and Prevention
(American CDC). However, the ELISA has cross-reactivity with
other flaviviruses when used for serodiagnosis. Additionally, the
above nucleic acid amplification methods are disadvantageous
because they require expensive equipment and are time-
consuming to perform. Furthermore, both virus isolation and
PRNT are tedious and technically complex and require over a
week to perform. Thus, there is an urgent need to develop a rapid
and simple diagnostic method for WNV to improve detection
efficiency.
Loop-mediated isothermal amplification (LAMP) is a novel
technique that can amplify DNA with high efficiency, specificity
and rapidity under isothermal conditions (Notomi et al.,
2000). Because this amplification technique requires isothermal
conditions, LAMP can be performed using only a simple
water bath. Moreover, LAMP can detect RNA templates by
using reverse transcriptase together with DNA polymerase for
amplification (Whiting and Champoux, 1998; Notomi et al.,
2000; Ge et al., 2013). Several RNA viruses have been successfully
detected using RT-LAMP assays (Kurosaki et al., 2007; Ge
et al., 2013). The gold immunochromatographic assay is another
technique that has been widely applied for the detection of
various viruses (Mikawa et al., 2009; Wang et al., 2010). Amplicon
detection using a vertical flow (VF) visualization strip has been
previously applied to accelerate and simplify the process of
interpreting LAMP assay results (Cui et al., 2012). In the current
study, we developed a RT-LAMP assay coupled with a VF
visualization strip for rapid, simple, and accurate visual detection
2http://www.cdc.gov/westnile/index.html
of WNV. Because of these characteristics, this RT-LAMP-VF
assay is useful for field laboratory diagnosis of WNV infection.
MATERIALS AND METHODS
Viruses and Extraction of Viral RNA
The recombinant rabies virus SRV9 strain was modified to
express the E protein (EP) of WNV (GenBank Accession:
DQ211652; rRABV-WNVE) and stored in our laboratory. The
recombinant virus was propagated in BSR cells, a clone of the
BHK-21 cell line (baby hamster kidney cells), which were grown
in Dulbecco’s modified Eagle’s medium (DMEM, Gibco, Grand
Island, NY, USA) supplemented with 5% fetal bovine serum (FBS,
Gibco, Grand Island, NY, USA) at 37◦C in an incubator. rRABV
was titrated in Neuroblastoma (NA) cell as described previously
(Wang et al., 2011). Viral RNA was extracted using a commercial
RNA extraction kit (RNeasy Mini Kit, Qiagen, Hilden, Germany).
All operations were performed according to the manufacturer’s
instructions.
Preparation of WNV RNA Standards
Artificial viral RNA encoding a partial WNV E gene sequence
(GenBank Accession: DQ211652) was synthesized; this construct
was modified via PCR to include the T7 promoter sequence at its
5′ terminus. The PCR products were transcribed in vitro using
T7 RNA polymerase (TaKaRa Biotechnology Co., Ltd., Dalian,
China) according to the manufacturer’s instructions. The RNA
transcripts were then purified and quantified, and 10-fold serial
dilutions of the RNA ranging from 107 to 100 copies per µl were
prepared.
Primer Design
The complete genome sequences of 30 strains of WNV isolated
over various years from different regions and disparate species
were analyzed, and the E gene of WNV was selected as the
target region for the RT-LAMP-VF assay (the alignment of
WNV E gene sequences was shown in Figure 1). Six primers,
targeting eight distinct regions of the gene, were designed for the
assay using the PrimerExplorer V4 program3. To detect reaction
products by VF, the LF and LB primers were 5′-labeled with biotin
and FITC. The details are shown in Figure 2 and Table 1. All
primers were synthesized by Sangon Biotech Biotechnology Co.,
Ltd., (Shanghai, China).
RT-LAMP-VF Reaction and Product
Detection
The RT-LAMP-VF assay was performed using a 25-µl total
reaction volume containing a mixture of 0.4 µM of the inner
primers FIP and BIP, 0.2 µM of the loop primers LF and
LB, 0.1 µM of the outer primers F3 and B3, 1.4 mM of each
deoxynucleoside triphosphate (dNTP), 8 mM MgSO4, 0.2 M
betaine, 5 U of avian myeloblastosis virus reverse transcriptase
(Bioer Technology Co., Ltd., Hangzhou, China), 8 U of Bst DNA
3http://primerexplorer.jp/elamp4.0.0/index.html
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FIGURE 1 | Alignment of West Nile virus (WNV) E gene sequences and positions of the primers used for RT-LAMP. The E gene of WNV was retrieved from
GenBank and analyzed using MegAlign software. Primers were designed based on a conserved region (nucleotides 2065–2277 of the genome). The GenBank
accession numbers of the aligned strains (from top to bottom) are HQ596519.1, AF260968.1, AF196520, KJ131504.1, AF196835.1, HQ705675.1, JN183897.1,
DQ164195.1, JF357960.1, JF899530.1, JF899531.1, JN817352.1, JN891.1, JN183890.1,HQ671797.1, JF920759.1, EU391640.1, JX442282.1, AF260969.1, AJ
965628.1, KM488117.1, HM756678.1, FJ265702.1, FJ265703.1, HM756661.1, JX015519.1, JN183893.1, KC493970.1, AF394221.1, and AF196520.1.
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FIGURE 2 | Details (location and sequence) for each primer used in our RT-LAMP-VF assay. The target region spanned nucleotides 2065–2277 of the
complete genome of WNV strain NY99 (GenBank Accession: DQ211652); this region is located in the E gene of WNV.
TABLE 1 | Primer sequences used for the RT-LAMP-VF assay.
Primer name Sequences (5′ to 3′) Genome position
LAMP-F3 GCCAACGCTAAGGTCCTG 2065–2082
LAMP-B3 TGAGGTGAACACCCCTCC 2260–2277
LAMP-FIP
(F1C + F2)
TCCAGACTTGTGCCAATGGTGA F1C:2148–2169
TTGGAACCACCCTTTGGAGA F2:2089–2108
LAMP-BIP
(B1C + B2)
GGCAAAGCCTTTACAACCACCC B1C:2179–2200
CAAAGTCCCAAGCTGTGTCT B2:2232–2251
LAMP-LFa Biotin-TGTTGTTCTCCTCTGCCCAC 2122–2141
LAMP-LBb FITC-TCAAAGGAGCGCAGAGACTAG 2201–2221
aThe 5′ ends of the LAMP-LF was labeled with biotin. bThe 5′ ends of the LAMP-LB
was labeled with FITC.
polymerase large fragment (New England BioLabs), and 5 µl of
target RNA. The mixture was incubated at varying temperatures
(58, 60, 62, 64, or 66◦C) for 60 min, followed by heating at 80◦C
for 2 min to terminate the reaction. The mixture was incubated
for different lengths of time (30, 40, 50 or 60 min) at the optimal
temperature. In parallel with the optimization of the reaction
time, two different concentrations were used: one group of the six
primers was used at the concentration described above, and the
other group was used at half this concentration. The RT-LAMP
products were detected using a VF visualization strip (Ustar
Biotech Co., Ltd., Hangzhou, China) as previously described (Cui
et al., 2012).
Specificity and Sensitivity of the
RT-LAMP-VF Assay
RNAs of rRABV-WNVE (105 TCID50/ml), JEV (105 PFU/ml),
dengue virus (DENV, 105 PFU/ml), and classical swine fever
virus (CSFV, 105 TCID50/ml) were extracted using a commercial
RNA extraction kit (RNeasy Mini Kit, Qiagen, Hilden, Germany).
All operations were performed according to the manufacturer’s
instructions, and the level of extracted RNAs was determined as
80–120 ng/µl. To evaluate the specificity of the RT-LAMP-VF
assay, 5 µl of RNAs extracted from above viruses and synthesized
RNA transcripts (107 copies/µl) were added into the optimal
reaction system.
The synthesized WNV RNA transcripts (1092 ng/µl) were
purified, quantified, and prepared as standard samples with a
concentration of 109 copies/µl. Then, 10-fold serial dilutions of
the standard samples (ranging from 107 to 100 copies/µl) were
used to assess the detection limits of the RT-LAMP-VF assay.
Evaluation of the RT-LAMP-VF Assay
Using Live Virus RNA
Viral RNA extracted from rRABV-WNVE was used to further
evaluate the performance ability of the RT-LAMP-VF assay.
rRABV-WNVE at a titer of 106.5 TCID50/ml was 10-fold serial
diluted in DMEM. RNA was extracted from the dilutions,
and the RNA samples were detected using the RT-LAMP-VF
assay.
Evaluation of the RT-LAMP-VF Assay
Using Clinical Specimens
The feasibility of using the RT-LAMP-VF assay to detect WNV
in clinical specimens was evaluated using 5-day-old and 3-week-
old ICR mice. The mice were randomly divided into seven
groups and intracerebrally infected with 10-fold dilutions of
rRABV-WNVE ranging from 106 to 101 TCID50 per mouse.
DMEM was used as a placebo. At 7 days post-infection, the mice
were submitted to humane euthanasia by cervical dislocation
under ketamine-xylazine anesthesia at a dose of 0.1 mL/10 g
body weight, after which their brains were collected. The brain
samples were then homogenized in phosphate-buffered saline
(PBS, 10 mM, pH 7.2–7.4). The homogenates were centrifuged
to remove debris, and the supernatants were collected for RNA
extraction and virus titration.
Total RNA was extracted from the brain homogenate using
an RNAeasy Mini Kit (Qiagen, Hilden, Germany). The extracted
RNA was then assessed using the RT-LAMP-VF assay and real-
time PCR as described previously (Yang et al., 2012). After viral
titration, the brain homogenate with a high titer of 7.03 Log
(TCID50/g tissue) was selected to evaluate the sensitivity of the
assay. To accomplish this, RNA was extracted from a 10-fold
serial dilution of the brain homogenate and measured using the
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RT-LAMP-VF assay; brain homogenate from healthy mice was
used as a control.
Ethics Statement
All animal studies performed in this work were approved by
the Animal Care and Use Committee of the Chinese People’s
Liberation Army (No. SYXK2009-045). All volunteers involved
in this study provided written informed consent for the use
of blood samples. All efforts were made to minimize animal
suffering.
RESULTS
Product Detection Using the
RT-LAMP-VF Assay
When using the VF visualization strip, a clearly visible red-purple
band at the control line was necessary for the test to be considered
valid. The appearance of two red-purple bands at both the test
and control lines was regarded as a positive result. If only the
band at the control line appeared, then the result was considered
negative (Figure 3).
Optimization of RT-LAMP-VF Reaction
Conditions
To determine the optimal conditions for the RT-LAMP-VF assay,
synthesized RNA transcripts were used as a template to optimize
both assay temperature and assay time. To determine the optimal
temperature for the assay, 60-min reactions were performed at
five different temperatures (58, 60, 62, 64, and 66◦C). The results
indicated that running the assay at 64◦C produced the strongest
amplification signal (Table 2); therefore, 64◦C was considered the
optimal temperature for the assay.
To determine the optimal duration of time required for the
RT-LAMP-VF assay, four different reaction times (30, 40, 50,
or 60 min) were compared at 64◦C. The best sensitivity and
FIGURE 3 | RT-LAMP-VF assay results. N denotes a negative result. In this
case, only one red-purple band appears at the control line. P denotes a
positive result. In this case, two red-purple bands appear: one at the test line
and one at the control line.
TABLE 2 | Reaction temperature optimization for RT-LAMPa.
Temperature/◦C RNA dilution (Copies/µl)
107 106 105 104 103 102 101 100
58 + + + + − − − −
60 + + + + − − − −
62 + + + + +b − − −
64 + + + + + − − −
66 + + + + − − − −
aThree replications were performed for each trial. bThe result was weakly positive.
specificity were found when the reaction lasted for 40 min at 64◦C
(Table 3). Therefore, an amplification time of 40 min was selected
as the optimal time for the assay.
As shown in Table 3, primer concentration was also optimized
when optimizing the reaction time. The following primer
concentrations were considered optimal: 0.4 µM for the inner
primers FIP and BIP, 0.2 µM for the loop primers LF and LB,
and 0.1 µM for the outer primers F3 and B3.
Specificity of the RT-LAMP-VF Assay
The analytical specificity of the RT-LAMP-VF assay was
determined using synthesized RNA transcripts and RNA
extracted from control viruses, including JEV, DENV, and CSFV.
As shown in Figure 4, all of the tested control samples appeared
identical to the blank control and produced only one red–purple
band at the location of the control line; therefore, all of these
samples produced negative test results. A positive test line was
observed when using synthetic WNV RNA transcripts and RNA
extracted from rRABV-WNVE as templates. Thus, because the
RT-LAMP-VF assay had no cross-reactivity with other viruses
related to WNV, the assay was considered to have high specificity.
Sensitivity of the RT-LAMP-VF Assay
Synthetic WNV RNA transcripts were 10-fold serially diluted to
create samples ranging in concentration from 107 to 100 copies
TABLE 3 | Reaction time optimization for RT-LAMPa.
Time/
min
Primers
group
RNA dilution (Copies/µl)
107 106 105 104 103 102 101 100
30 1b + + +d +d − − − −
2c + + + + − − − −
40 1 + + + + + + − −
2 + + + + − − − −
50 1 + + + + + − − −
2 + + + + − − − −
60 1 + + + +d − − − −
2 + + + + + − − −
aThree replications were performed for each trial. bThe six primers was used as
described as bellow: 0.4 µM each of inner primers FIP and BIP, 0.2 µM loop
primers LF and LB, 0.1 µM outer primers F3 and B3. cThe six primers was used
as described as bellow: 0.2 µM each of inner primers FIP and BIP, 0.1 µM loop
primers LF and LB, 0.05 µM outer primers F3 and B3. dThe result was weakly
positive.
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FIGURE 4 | RT-LAMP-VF assay specificity. The specificity of the
RT-LAMP-VF assay was determined by analyzing synthesized RNA transcripts
and RNA extracted from rRABV-WNVE, JEV, DENV, and CSFV. N: blank
control; 1: synthesized RNA transcripts; 2: rRABV-WNVE RNA; 3: JEV RNA;
4: DENV RNA; 5: CSFV RNA.
per µl. These samples were then used to assess the sensitivity of
the RT-LAMP-VF assay. After a 40-min amplification reaction,
negative results were produced at concentrations lower than 102
copies/µl. Thus, the RT-LAMP-VF assay had a detection limit of
102 copies/µl of synthetic RNA (Figure 5).
Evaluation of the RT-LAMP-VF Assay
Using Live Virus RNA
Total RNA was extracted from serial dilutions of rRABV-WNVE
and then assessed using the RT-LAMP-VF assay. As shown in
Figure 6, RNA extracted from a 105-fold dilution of virus (101.5
TCID50/ml) produced positive results when assayed; thus, the
detection limit of the assay for rRABV-WNVE in cell culture
is 101.5 TCID50/ml. To confirm the absence of non-specific
reactions, total RNA extracted from DMEM and NA cells was also
evaluated; no amplification was found in either case.
FIGURE 5 | RT-LAMP-VF assay sensitivity. The sensitivity of the
RT-LAMP-VF assay was analyzed by using tenfold serial dilutions of
synthesized RNA transcripts. N: blank control; 1: 107 copies/µl; 2: 106
copies/µl; 3: 105 copies/µl; 4: 104 copies/µl; 5: 103 copies/µl; 6: 102
copies/µl; 7: 101 copies/µl; 8: 100 copies/µl.
FIGURE 6 | Evaluation of the RT-LAMP-VF assay using live virus. The
sensitivity of the RT-LAMP-VF assay was analyzed by using 10-fold serial
dilutions of recombinant virus (rRABV-WNVE). N: blank control; 1: 106.5
TCID50/ml; 2: 105.5 TCID50/ml; 3: 104.5 TCID50/ml; 4: 103.5 TCID50/ml;
5: 102.5 TCID50/ml; 6: 101.5 TCID50/ml; 7: 100.5 TCID50/ml; 8: 10−0.5
TCID50/ml.
Evaluation of the RT-LAMP-VF Assay
Using Clinical Specimens
Brain tissues collected from mice infected with rRABV-WNVE
were used as clinical specimens to further evaluate the RT-
LAMP-VF assay. As shown in Table 4, rRABV-WNVE mRNA
in the range of 6.14–10.02 Log(copy number/g tissue) was
extracted from the brains of rRABV-WNVE-infected suckling
mice, corresponding to viral titers in the range of 4.31–7.35
Log(TCID50/g tissue); the RT-LAMP-VF results were positive
across this entire range. Unlike the suckling mice, substantially
less rRABV-WNVE mRNA was extracted from the brains of
3-week-old mice brain: from 2.16 to 5.56 Log(copy number/g
tissue) mRNA was extracted, and two of the samples from the
102 group were not detected. Thus, viral titers could not be
determined for the 3-week-old mice; however, all of the RT-
LAMP-VF results were positive, except for three samples in the
101 and 102 groups (Table 5).
The sensitivity of the RT-LAMP-VF assay was further
evaluated using brain homogenates collected from rRABV-
WNVE-infected mice; brain homogenates from uninfected mice
were used as a control. After diluting the rRABV-WNVE-infected
TABLE 4 | Assay detection results from suckling mouse brain tissue
samples.
Samplesa mRNA [Log (copy
number/g tissue)]
Virus titers [Log
(TCID50/g tissue)]
RT-LAMP
Blank Not detected Not detected −
Negative 1 Not detected Not detected −
Negative 2 Not detected Not detected −
101 1 8.05 5.32 +
2 7.21 6.67 +
3 9.59 5.67 +
4 6.14 6.66 +
102 1 9.29 6.15 +
2 10.02 7.03 +
3 9.28 7.27 +
4 7.30 6.18 +
103 1 8.93 5.46 +
2 8.46 6.24 +
3 8.14 6.33 +
4 7.65 5.68 +
104 1 7.58 6.18 +
2 9.45 5.09 +
3 7.35 7.21 +
4 6.51 6.16 +
105 1 8.96 6.62 +
2 8.79 4.31 +
3 7.48 7.35 +
4 7.17 7.34 +
106 1 8.38 5.22 +
2 8.28 6.65 +
3 9.27 4.35 +
4 8.82 6.23 +
a101, 102, 103, 104, 105, 106 are the virus dose which was infected in mice
(TCID50/mouse); 1, 2, 3 are different numbers of mouse in each group.
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TABLE 5 | Assay detection results from 3-week-old mouse brain tissue
samples.
Samplesa mRNA [Log (copy
number/g tissue)]
Virus titers [Log
(TCID50/g tissue)]
RT-LAMP
Blank Not detected Not detected −
Negative 1 Not detected Not detected −
Negative 2 Not detected Not detected −
101 1 2.36 Not detected +
2 4.11 Not detected +
3 2.16 Not detected −
102 1 Not detected Not detected −
2 Not detected Not detected −
3 2.49 Not detected +
103 1 4.73 Not detected +
2 3.02 Not detected +
3 5.11 Not detected +
104 1 3.23 Not detected +
2 5.76 Not detected +
3 3.52 Not detected +
105 1 3.53 Not detected +
2 4.00 Not detected +
3 4.13 Not detected +
106 1 4.68 Not detected +
2 4.97 Not detected +
3 5.56 Not detected +
a101, 102, 103, 104, 105, 106 are the virus dose which was infected in mice
(TCID50/mouse); 1, 2, 3, 4 are different numbers of mouse in each group.
brain homogenates by 105-fold, the RT-LAMP-VF assay still
produced positive results. Therefore, the sensitivity of the
assay for rRABV-WNV-infected mouse brain tissue is 101.33
TCID50/ml.
DISCUSSION
With the unexpected appearance of WNV in many countries,
it is becoming increasingly important to develop adequate
surveillance methods for WNV. Such methods are needed not
only in countries where WNV infections are epidemic but also
in countries threatened by WNV infection and even in countries
where WNV infection has not yet spread. In addition, the
development of a rapid and reliable method for diagnosing
WNV is critically important for the prevention of infection,
the implementation of appropriate countermeasures, and the
optimization of healthcare resources. In the current study, we
described the development of a RT-LAMP-VF assay that provides
a simple and rapid method to detect WNV infection.
To accomplish the above, we analyzed the complete genome
sequences of 30 strains of WNV isolated over various years from
different regions and disparate species, including representative
strains from WNV lineages 1, 2, and 3. Bases on this analysis,
we selected two target regions for RT-LAMP-VF, a region located
in the E gene and a region located in the 5′-UTR and spanning
part of the C gene. However, when using the RT-LAMP-VF assay
to detect the latter region, the assay produced low sensitivity
(data not shown). Several previously reported molecular biology
methods have used the E gene as a target sequence with excellent
results, consistent with our previous study (Parida et al., 2004;
Zink et al., 2013; Kumar et al., 2014). Therefore, we chose a
relatively conserved region of the genome spanning nucleotide
positions 2065–2277 as a target sequence.
We designed a set of six primers (including two loop primers)
targeting eight regions located in the conserved region of
the WNV E gene to ensure high specificity for nucleic acid
amplification. The use of loop primers accelerated the reaction
time, enabling the reaction to be completed in less than half the
time required for our original LAMP assay (Nagamine et al.,
2002). Indeed, amplification could be completed within 40 min,
which is faster than other molecular biology methods.
Compared to other molecular biology detection technologies,
the RT-LAMP-VF assay is economical, technically simple,
and rapid. For this assay, reverse transcription and cDNA
amplification are performed in a single step, and no additional
procedures are needed. Moreover, some conventional molecular
biology methods, such as RT-PCR, nested RT-PCR and real-
time PCR, have inherent flaws; in particular, specialized PCR
instruments are needed, and temperature must be precisely
controlled for a lengthy period of time. This inhibits the
application of these methods in rural and remote areas (Deng
et al., 2015). As the reaction conditions for RT-LAMP-VF
are isothermal, only a water bath is needed to complete the
assay, offering a measure of practicality for field laboratories in
economically impoverished areas.
Parida et al. (2004) developed a RT-LAMP method for
the rapid detection of WNV. In this method, the results
were analyzed using agarose gel electrophoresis or real-time
turbidity analysis (Parida et al., 2004). Generally, the use of gel
electrophoresis to detect amplification products increases the
risk of product contamination and degradation, while real-time
turbidity analysis suffers from background interference (Iwamoto
et al., 2003; Ge et al., 2013). In the current study, we modified
the RT-LAMP technique by using two loop primers labeled with
FITC and biotin. This allowed labeled amplification products
to be analyzed using a VF visualization strip housed inside of
an enclosed, plastic, leak-proof device, without the need for an
electrophoresis apparatus or a turbidimeter. Within the strip,
the FITC-labeled amplification products can bind to the anti-
FITC antibody located on the test line, and the biotin-labeled
amplification products are captured by colloidal gold particles
conjugated to the anti-biotin antibodies (Chow et al., 2008; Cui
et al., 2012). Using this strategy, we reduced not only the reaction
time but also the chances of product contamination. Moreover,
the results of the assay can be directly visualized within 2 min,
and the plastic device was designed to prevent leakage of the
amplification products.
As encephalitis is the main clinical symptom of WNV
infection, we used brain samples from Charadrius alexandrinus
and Recurvirostra avosetta to evaluate the specificity of the
RT-LAMP-VF assay. All of the samples were negative (data
not shown). Clinical specimens infected with WNV (e.g.,
blood and brain tissue) are difficult to obtain in non-endemic
countries such as China; however, we hypothesized that using
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a recombinant virus expressing the E gene of WNV would
produce similar assay results. Therefore, we assessed brain
tissues collected from rRABV-WNVE-infected mice as clinical
specimens in this study. Our results indicated that the assay could
successfully detect clinical samples infected with the recombinant
virus. Additionally, the assay thresholds for detecting cell
culture samples infected with the recombinant virus (sensitivity:
101.5 TCID50/ml) and mouse brain tissues infected with the
recombinant virus (sensitivity: 101.33 TCID50/ml) were nearly
identical, which indicated that the presence of tissue-specific
RNA did not influence the performance of the RT-LAMP-VF
assay. Furthermore, three of the samples collected from the 3-
week-old ICR mice had very little rRABV-WNVE mRNA, and the
RT-LAMP-VF results were negative for these samples. This result
indicates that the assay’s results may be ambiguous in cases of very
small viral loads. Under such conditions, sample detection should
be performed in duplicate or combined with other methods. To
simulate brief viremia, blood samples from healthy volunteers
were mixed with rRABV-WNVE and evaluated using the RT-
LAMP-VF assay. In this case, similar results were produced
as those generated by the rRABV-WNVE-infected mouse brain
tissues (data not shown). The broad capacity to accurately
identify the presence of WNVE in clinical specimens validated
the RT-LAMP-VF assay for the detection of WNV infection.
In summary, we developed a method to diagnose WNV
using isothermal amplification combined with a VF visualization
strip. This method was shown to have high specificity and
high sensitivity for the detection of WNV. To simulate
clinical samples, brain tissue infected with a recombinant virus
expressing the E gene of WNV was evaluated. The results
showed that the assay could accurately detect the virus with no
interference from tissue-specific RNA. Furthermore, in the clinic,
viral RNA loads reach higher levels than the detection limit of
our assay (Ramos et al., 2012; Caraballo et al., 2015). Collectively,
the above results demonstrate that our RT-LAMP-VF assay offers
rapid, simple and effective diagnostic identification of WNV
infection.
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